OpenVSafe by OpenVAERS
Search V-safe

C3D-11402-21140

2 vaccinations 3 coded responses 9 check-ins 3 free-text entries 0 call cases
Sex
Male
Age at first dose
05-11
ZIP prefix
070 / NJ
Registered
2021-11-29
Relationship
Child or adolescent in my care
Guardian
C5Q-31618-39832
Race
Multiracial
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-11-16
    Dose 1 — Pfizer-BioNTech
  2. 2021-11-29
    Registered in v-safe
  3. 2021-11-29
    Health check-in — day 7, dose 1, dependent
    Feeling: Good · None
    Adult check-in
  4. 2021-11-30
    Health check-in — day 14, dose 1, dependent
    Feeling: Good
    Adult check-in
  5. 2021-12-07
    Dose 2 — Pfizer-BioNTech
  6. 2021-12-10
    Survey response — days 1–6 daily, dose 2, dependent
    MedDRA: Injection site pain, Pyrexia — Feeling: Good
    Free text: Minor fever and pain at the injection site the day after receiving 2nd vaccine dose.
    MedDRA releases: 2024-11 · check-in free text available
  7. 2021-12-13
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  8. 2021-12-14
    Health check-in — day 7, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  9. 2022-01-06
    Health check-in — day 28, dose 2, dependent
    Feeling: Good
    Adult check-in
  10. 2022-01-18
    Health check-in — day 42, dose 2, dependent
    Feeling: Good
    Adult check-in
  11. 2022-03-08
    Survey response — 3 months, dose 2, dependent
    MedDRA: Nasopharyngitis, SARS-CoV-2 test negative — Feeling: Good
    Free text: Had a minor cold for a few days. Tested negative for COVID.
    MedDRA releases: 2024-11 · check-in free text available
  12. 2022-06-07
    Survey response — 6 months, dose 2, dependent
    MedDRA: Oropharyngeal pain, Pyrexia, SARS-CoV-2 test negative — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: (b)(6) had a sore throat and some fever on May 2, 2022. Despite frequent (daily) testing since the end of April he never tested positive for COVID.
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-11-16Pfizer-BioNTech No
22021-12-07Pfizer-BioNTech No

Free text

Release 10 — days 1–6 daily, dose 2, dependent

2021-12-10

Systemic reaction (other): Minor fever and pain at the injection site the day after receiving 2nd vaccine dose.

Release 11 — 3 months, dose 2, dependent

2022-03-08

Symptoms: Had a minor cold for a few days. Tested negative for COVID.

Release 11 — 6 months, dose 2, dependent

2022-06-07

Symptoms: (b)(6) had a sore throat and some fever on May 2, 2022. Despite frequent (daily) testing since the end of April he never tested positive for COVID.
redacted (b)(6)

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDNasopharyngitis · · ✓
SDOropharyngeal pain · · ✓
SDPyrexia · · ✓
SDSARS-CoV-2 test negative · · ✓
SROInjection site pain · · ✓
SROPyrexia · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release